Prevymis (letermovir) - Merck (MSD)
Letermovir as Cytomegalovirus Prophylaxis Among Pediatric Solid Organ Transplant Recipients: A Multicenter Cross-Sectional Survey (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 1657; Pres time: Oct 22, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available 
Clinical • Cytomegalovirus Infection • Infectious Disease
https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=839372&mode=posterInfo
 
Gabriela Espinoza-Candelaria, MD; Kathryn E. Weakley, MD, MSc; Monica I. Ardura, DO, MSCS (she/her/hers); Anna R. Huppler, MD; Christopher Ouellette, MD; Elizabeth D. Knackstedt, MD; Sruti S. Nadimpalli, MD, MPH; Taylor Heald-Sargant, MD, PhD (she/her/hers); Marian G. Michaels, MD; Benjamin Hanisch, MD; Justin K. Chen, PharmD, BCTXP; Marc Foca, MD
 
Sep 6, 2026
 
Prev Next